More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Garivulimab (Anti-B7-H1 / PD-L1 / CD274)

Garivulimab (Anti-B7-H1 / PD-L1 / CD274)

A2778
Selleck Chemicals
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Selleck Chemicals
  • Product Name
    Garivulimab (Anti-B7-H1 / PD-L1 / CD274)
  • Delivery Days Customer
    9
  • Certification
    Research Use Only
  • Estimated Purity
    ...
  • Scientific Description
    Garivulimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G1 (IgG1)-variant monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 144.3 KD.
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203